EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Klinische Studie (Phase III)Multizentrische StudieOpen Access

Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes

Lynn Ang iD, Sejal Gunaratnam, Yiyuan Huang iD, Brendan R Dillon, Catherine L Martin, Aaron Burant, Jacob Reiss, Pennelope Blakely iD, Alexi Vasbinder iD, Lili Zhao iD, Kara Mizokami-Stout iD, Yaling Tang und 6 weitere

Journal of the American Heart Association · 07.01.2025 · 14 (1)

DOI: 10.1161/jaha.124.036787 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Journal of the American Heart Association, erschienen am 07.01.2025. Verfasst von Lynn Ang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes University of Michigan Ann Arbor MI USA. Hauptthemen laut MEDLINE: Biomarkers, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Heart Rate. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Cardiovascular autonomic neuropathy (CAN) and inflammation predict more severe outcomes in type 1 diabetes (T1D). However, the link between CAN and inflammation in T1D remains unclear. We examined associations between CAN measures and inflammatory biomarkers in individuals with T1D. Methods and Results In a cross‐sectional study, we measured cardiovascular autonomic reflex tests and heart rate variability (established CAN measures) and a panel of 39 inflammatory biomarkers, including soluble urokinase plasminogen activator receptor (suPAR), in T1D participants of the TINSAL‐T1DN (Targeting Inflammation with Salsalate in Individuals with T1D Neuropathy) trial (n=57, discovery), and the PERL (Preventing Early Renal Loss in Diabetes) trial (n=468, validation). Amongst 39 inflammatory biomarkers measured in TINSAL‐T1DN, suPAR levels had the strongest negative correlations with CAN measures: expiration/inspiration ( r =−0.48), Valsalva ( r =−0.28), 30:15 ( r =−0.37), SD of the normal RR interval ( r =−0.37), and root mean square of differences of successive RR intervals ( r =−0.31) (all P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersDiabetes Mellitus, Type 1Diabetic NeuropathiesHeart RateInflammationReceptors, Urokinase Plasminogen ActivatorAdultFemaleHumansMaleMiddle AgedAutonomic Nervous SystemAutonomic Nervous System DiseasesCardiovascular DiseasesCardiovascular SystemCross-Sectional StudiesInflammation Mediators

Stichwörter der Autor:innen

biomarkerscardiovascular autonomic neuropathycardiovascular autonomic reflex testsheart rate variabilityinflammationsoluble urokinase plasminogen activator receptortype 1 diabetes

Substanzen

BiomarkersInflammation MediatorsPLAUR protein, humanReceptors, Urokinase Plasminogen Activator

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes University of Michigan Ann Arbor MI USA.
  • Life Science Informatics University of Michigan Ann Arbor MI USA.
  • Department of Biostatistics University of Michigan Ann Arbor MI USA.
  • Department of Medicine NYU Grossman School of Medicine New York NY USA.
  • Quality Department University of Michigan Ann Arbor MI USA.
  • Department of Internal Medicine, Division of Cardiology University of Texas Medical Branch Galveston TX USA.

ORCID-Profile: Lynn Ang, Yiyuan Huang, Pennelope Blakely, Alexi Vasbinder, Lili Zhao, Kara Mizokami-Stout, Alessandro Doria, Cathie Spino, Mousumi Banerjee, Salim S Hayek, Rodica Pop-Busui

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Ang, L., Gunaratnam, S., Huang, Y., Dillon, B. R., Martin, C. L., Burant, A., Reiss, J., Blakely, P., Vasbinder, A., Zhao, L., Mizokami-Stout, K., Tang, Y., Feldman, E. L., Doria, A., Spino, C., Banerjee, M., Hayek, S. S., & Pop-Busui, R. (2025). Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes. Journal of the American Heart Association, 14(1). https://doi.org/10.1161/jaha.124.036787

Vancouver

Ang L, Gunaratnam S, Huang Y, Dillon BR, Martin CL, Burant A, et al. Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes. Journal of the American Heart Association. 2025;14(1). doi:10.1161/jaha.124.036787

BibTeX
@article{Ang2025,
  author = {Ang, Lynn and Gunaratnam, Sejal and Huang, Yiyuan and Dillon, Brendan R and Martin, Catherine L and Burant, Aaron and Reiss, Jacob and Blakely, Pennelope and Vasbinder, Alexi and Zhao, Lili and Mizokami-Stout, Kara and Tang, Yaling and Feldman, Eva L and Doria, Alessandro and Spino, Cathie and Banerjee, Mousumi and Hayek, Salim S and Pop-Busui, Rodica},
  title = {Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {1},
  doi = {10.1161/jaha.124.036787}
}
Kostenlos starten →